Regulation of the signal transduction program by drugs
- 31 December 1997
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 37, 35-55
- https://doi.org/10.1016/s0065-2571(96)00025-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Molecular mechanisms in the antiproliferative action of quercetinLife Sciences, 1997
- Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetinLife Sciences, 1995
- Quercetin Down-Regulates Signal Transduction in Human Breast Carcinoma CellsBiochemical and Biophysical Research Communications, 1995
- Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cellsLife Sciences, 1994
- Inhibition by tiazofurin of inosine 5′-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomasGynecologic Oncology, 1992
- Tiazofurin: Biological effects and clinical usesThe International Journal of Cell Cloning, 1990
- Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor InhibitorsNucleosides and Nucleotides, 1982
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975